Axsome Therapeutics AXSM

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$2.31 (-1.86%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Axsome Therapeutics (AXSM)
    Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $122.17

    • Market Cap

      $5.96 Billion

    • Price-Earnings Ratio

      -20.40

    • Total Outstanding Shares

      48.77 Million Shares

    • Total Employees

      589

    • Dividend

      No dividend

    • IPO Date

      November 19, 2015

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      One world trade center, 22nd floor, New york, NY, 10007

    • Homepage

      https://www.axsome.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Net Cash Flow From Investing Activities, Continuing$-270,000
    Net Cash Flow From Financing Activities, Continuing$57.84 Million
    Net Cash Flow From Operating Activities, Continuing$-128.41 Million
    Net Cash Flow$-70.84 Million
    Net Cash Flow From Investing Activities$-270,000
    Net Cash Flow, Continuing$-70.84 Million

    Income Statement

    January 1, 2024 to December 31, 2024
    MetricValue
    Income Tax Expense/Benefit$85,000
    Other Operating Expenses$67.82 Million
    Research and Development$187.08 Million
    Operating Expenses$666.25 Million
    Revenues$385.69 Million
    Net Income/Loss$-287.22 Million

    Comprehensive Income

    January 1, 2024 to December 31, 2024
    MetricValue
    Comprehensive Income/Loss$-287.22 Million
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss Attributable To Parent$-287.22 Million

    Balance Sheet

    January 1, 2024 to December 31, 2024
    MetricValue
    Liabilities And Equity$568.50 Million
    Other Current Liabilities$129.88 Million
    Accounts Payable$72.00 Million
    Inventory$15.73 Million
    Noncurrent Assets$83.43 Million
    Noncurrent Liabilities$281.38 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AXSM from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.